Hypoxia reverses a proteostasis-linked mitochondrial disease via HTRA2-CLPB axis
TL;DR Summary
Reducing oxygen levels (hypoxia) can rescue a mitochondrial disease driven by proteostasis defects linked to the HTRA2–CLPB axis, extending oxygen-based therapy concepts beyond primary respiratory chain mutations.
Reading Insights
Total Reads
1
Unique Readers
18
Time Saved
12 min
vs 13 min read
Condensed
99%
2,440 → 27 words
Want the full story? Read the original article
Read on Nature